CTT Pharmaceutical Holdings: CEO bought 5,880 shares

What happened The filing shows the CEO and director bought 5,880 shares in an open market or private purchase at $0.06 per share, totaling $335.

Key details

• Transaction date: Oct 26, 2026; price: $0.06 per share; shares acquired: 5,880; total value: $335.
• Acquisition type: open market or private purchase (transaction code P).
• Shares owned after the transaction: not reported in the provided filing.
• Footnotes/plans: no footnotes or 10b5-1 plan information provided in the supplied information.
• Filing date: Oct 26, 2026; period of report: Oct 22, 2026.

Why it may matter

• The reported activity was a purchase (code P), not an option exercise, gift, or tax-withholding event.
• A filing does not show why the insider traded or why the company acted.